This compound is a benzodiazepine impurity reference standard, specifically a derivative of chlordiazepoxide. It is characterized by an oxazireno ring fused to a benzodiazepine core, with chlorine and methyl substituents.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 17953-23-0
8-Chloro-6-(2-fluorophenyl)-1-methyl-3a,4-dihydro-3H-imidazo[1,5-a][1,4]benzodiazepine
pharmaceutical raw material
Ethyl 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
pharmaceutical raw material
7-Bromo-5-(6-methylpyridin-2-yl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
pharmaceutical raw material
Bupivacaine N-Oxide Hydrochloride Salt
pharmaceutical raw material
17a-Dutasteride
pharmaceutical raw material
(S)-Mirabegron
pharmaceutical raw material
(2R)-Avibactam Sodium Salt
pharmaceutical raw material
8-chloro-N-methyl-9b-phenyl-3,5-dihydrooxazireno[2,3-d][1,4]benzodiazepin-4-imine
XSEVNHXJQHVDDQ-UHFFFAOYSA-N
CN=C1CN2C(O2)(C3=C(N1)C=CC(=C3)Cl)C4=CC=CC=C4
—